Position in IBRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,316,094
+$3,487,707 QoQ
Shares Held
3,234,277
-0.1% QoQ
Ownership
0.305%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 403 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Derivatives in IBRX
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
0
PutValue
$437,976
PutShares
69,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. IBRX ranks #97 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in IBRX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,316,094 | 3,234,277 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $24,828,387 | 3,237,078 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,182,314 | 6,152,684 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $2,806,080 | 1,140,683 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,194,382 | 831,206 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,181,265 | 1,056,899 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $2,922,331 | 1,141,536 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $4,794,732 | 1,288,907 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $437,976 | 69,300 | Put | Defined | 2024-08-13 | |
| 2024-06-30 | $6,477,841 | 1,024,975 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,526,595 | 1,215,381 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $57,730 | 11,500 | Put | Defined | 2024-05-14 | |
| 2023-12-31 | $6,418,762 | 1,278,638 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $722,921 | 427,764 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $759,273 | 273,120 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $643,480 | 353,561 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $5,839,239 | 1,151,724 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $2,812,238 | 565,843 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $2,123,524 | 570,840 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,289,860 | 408,175 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,591,129 | 261,699 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $2,198,775 | 225,747 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $2,804,691 | 196,407 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,926,310 | 81,142 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 NK | — | 56,619 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 NK | — | 57,700 | Shares | Defined | 2020-11-13 | |
| 2020-03-31 NK | — | 80,447 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||